United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$11Mraised across 1 round since 2021, from 1 source
Hatteras Venture PartnersLead
Osage University Partners
Elm Street VenturesReported by Hatteras Venture PartnersSEC filing: $11M sold, first sale Dec 2020
Missing a round, or an investor who was in one? Tell us.
Artizan Biosciences, Inc.'s investors include Hatteras Venture Partners, Biohaven Therapeutics Ltd, Osage University Partners, Elm Street Ventures and CT Innovations. Hatteras Venture Partners led its latest round.
Artizan Biosciences, Inc. has raised $11M across 1 round since 2021.
Artizan Biosciences, Inc.'s most recent round was a Series A of $11M in Mar 2021, led by Hatteras Venture Partners.
Its most recent round, $11M in Mar 2021, is also its largest on record.
Artizan Biosciences, Inc.'s first round on record, in Mar 2021, was backed by Hatteras Venture Partners, Biohaven Therapeutics Ltd and Osage University Partners and 2 others.
Artizan Biosciences, Inc.'s latest named round is a Series A, in Mar 2021.
Artizan Biosciences, Inc. is based in the United States.
Hatteras Venture Partners led the Series A in 2021.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
